A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)

NCT01000818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection
HIV Infections

Interventions

DRUG: MK0518 (Raltegravir)
DRUG: famotidine
DRUG: omeprazole

Sponsor

Merck Sharp & Dohme LLC